Frontage Holdings Corporation (FGHQF)

Market Cap	307.84M
Revenue (ttm)	254.91M
Net Income (ttm)	791.00K
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	389.18
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,000
Average Volume	125,025
Open	0.1010
Previous Close	0.1200
Day's Range	0.1010 - 0.1010
52-Week Range	0.1010 - 0.3266
Beta	0.56
RSI	n/a
Earnings Date	Mar 28, 2025

About Frontage Holdings

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such as pharmacology, medical writing, an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Employees: 1,560
• Stock Exchange: OTCMKTS
• Ticker Symbol: FGHQF

Financial Performance

In 2024, Frontage Holdings's revenue was $254.91 million, a decrease of -1.90% compared to the previous year's $259.86 million. Earnings were $791,000, a decrease of -92.68%.